Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Budoprutug by Climb Bio for Membranous Glomerulonephritis: Likelihood of Approval
Budoprutug is under clinical development by Climb Bio and currently in Phase II for Membranous Glomerulonephritis. According to GlobalData, Phase...